Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiggam, M. I.
Right arrow Articles by Bell, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiggam, M. I.
Right arrow Articles by Bell, P. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 20, Issue 9 1347-1352, Copyright © 1997 by American Diabetes Association


ARTICLES

Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study

MI Wiggam, MJ O'Kane, R Harper, AB Atkinson, DR Hadden, ER Trimble and PM Bell
Sir George E Clark Metabolic Unit, Royal Victoria Hospital, Belfast, Northern Ireland, U.K.

OBJECTIVE: To compare the efficacy of an extended insulin regimen using correction of hyperketonemia as endpoint with a more conventional regimen in the treatment of diabetic ketoacidosis. RESEARCH DESIGN AND METHODS: A total of 22 patients admitted to a Belfast teaching hospital with clinical and biochemical features of diabetic ketoacidosis (pH < 7.25 and/or bicarbonate < 16 mmol/l) were randomized to either conventional or extended insulin regimens. In the conventional regimen, insulin was administered at 5 U/h until near-normoglycemia (blood glucose < or = 10 mmol/l) and then administered at a reduced rate until clinical recovery. In the extended regimen, administration of insulin at 5 U/h was continued beyond attainment of normoglycemia, until resolution of hyperketonemia (3-hydroxybutyrate < 0.5 mmol/l). Main outcome measures were 3-hydroxybutyrate and bicarbonate levels during the 24 h after attainment of near-normoglycemia. RESULTS: After near-normoglycemia, correction of hyperketonemia was achieved earlier with the extended treatment (5.9 +/- 0.8 vs. 21.8 +/- 3.4 h, P = 0.0004 [mean +/- SD]). The area under the curve of 3-hydroxybutyrate against time for 24 h after near-normoglycemia was reduced with the extended treatment (24.9 +/- 3.8 vs. 55.9 +/- 6.7 mmol.l-1.h-1, P = 0.001). These differences remained statistically significant after adjustment for higher baseline levels of 3-hydroxybutyrate at near-normoglycemia in the extended treatment group. Bicarbonate levels at 6 and 12 h after near-normoglycemia were not significantly different between groups. CONCLUSIONS: The extended insulin regimen, which was easy to implement at ward level, produced a more rapid resolution of ketosis than the conventional regimen.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
J. Wolfsdorf, N. Glaser, and M. A. Sperling
Diabetic Ketoacidosis in Infants, Children, and Adolescents: A consensus statement from the American Diabetes Association
Diabetes Care, May 1, 2006; 29(5): 1150 - 1159.
[Full Text] [PDF]


Home page
QJMHome page
P.M. Bell, M.I. Wiggam, and D.R. Hadden
Recent advances in the monitoring and management of diabetic ketoacidosis
QJM, April 1, 2005; 98(4): 318 - 318.
[Full Text] [PDF]


Home page
CMAJHome page
J.-L. Chiasson, N. Aris-Jilwan, R. Belanger, S. Bertrand, H. Beauregard, J.-M. Ekoe, H. Fournier, and J. Havrankova
Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state
Can. Med. Assoc. J., April 1, 2003; 168(7): 859 - 866.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Clin. Chem., March 1, 2002; 48(3): 436 - 472.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
G. R. McAnulty, H. J. Robertshaw, and G. M. Hall
Anaesthetic management of patients with diabetes mellitus
Br. J. Anaesth., July 1, 2000; 85(1): 80 - 90.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Fulop, V. Murthy, A. Michilli, J. Nalamati, Q. Qian, and A. Saitowitz
Serum {beta}-Hydroxybutyrate Measurement in Patients With Uncontrolled Diabetes Mellitus
Arch Intern Med, February 22, 1999; 159(4): 381 - 384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.